Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Health's Clinical Decision Support Solutions

Molecular Health has launched two new clinical decision support solutions, Molecular Health Guide Workbench Manager and Molecular Health Guide Clinical Annotation Service. These services are based on Dataome, Molecular Health's proprietary cloud-based software platform for the automated analysis, clinical interpretation, and reporting of genetic alterations from next-generation sequencing-based tests. 

The Workbench Manager offers tools for analyzing patient's tumor data and generating custom reports. These reports cover actionable variants and summarize potentially effective and ineffective treatment options as well as treatments that may pose a higher risk of adverse reactions to patients. The software also provides a tool for matching patients to clinical trials. 

The Clinical Annotation Service enables automated delivery of clinically-reviewed annotations for actionable variants. Through the service, Molecular Health provides clinicians with clinical variant narratives, evidence-based treatment options, matching trials, and other supplemental data such as drug descriptions and drug-drug interactions. The technology can be integrated into existing workflows, pipeline management, and reporting systems for use by high-throughput laboratories and other high-volume customers.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.